CN108057089B - Moxibustion powder for treating chronic obstructive pulmonary disease and preparation method and application thereof - Google Patents
Moxibustion powder for treating chronic obstructive pulmonary disease and preparation method and application thereof Download PDFInfo
- Publication number
- CN108057089B CN108057089B CN201810156580.1A CN201810156580A CN108057089B CN 108057089 B CN108057089 B CN 108057089B CN 201810156580 A CN201810156580 A CN 201810156580A CN 108057089 B CN108057089 B CN 108057089B
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- chronic obstructive
- obstructive pulmonary
- pulmonary disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines, and discloses moxibustion powder for treating chronic obstructive pulmonary disease, and a preparation method and application thereof. The invention takes red ginseng and hairyvein agrimony as monarch drugs; bulbus Fritillariae Cirrhosae, fructus Perillae, semen Lepidii preparata, and semen Sinapis Albae as ministerial drugs, and adjuvant monarch drugs for enhancing dredging, removing blood stasis, and smoothing lung qi to achieve antitussive and expectorant effects; fructus Psoraleae, lignum Santali albi, exocarpium Citri rubrum, radix Paeoniae Rubra, flos Caryophylli, cortex Cinnamomi, and Moschus as adjuvant drugs; the old moxa fine powder is used for tonifying qi and strengthening the middle warmer, and is used for harmonizing the medicines to play the effects of clearing lung and relieving cough, and reducing phlegm and relieving asthma, thereby treating the chronic obstructive pulmonary disease.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to moxibustion powder for treating chronic obstructive pulmonary disease and a preparation method and application thereof.
Background
Chronic obstructive pulmonary disease is a common disease that can be prevented and treated characterized by persistent respiratory symptoms and airflow limitation, often associated with airway and/or alveolar abnormalities caused by significant exposure to toxic particles or gases. Patients with chronic obstructive disease have poor prognosis, die of respiratory failure and pulmonary heart disease, and are the fourth leading cause of death worldwide, and are predicted to become the third leading cause of death worldwide in 2020. The chemical medicines for symptomatic treatment of chronic obstructive pulmonary disease include: therapeutic agents include bronchodilators (beta 2 receptor agonists, anticholinergics, and theophyllines), hormones, phosphodiesterase-4 (PDE-4) inhibitors, and other drugs (mucolytics, antioxidants, immunomodulators, vaccines, and the like). Non-drug therapies include oxygen therapy, ventilatory support, rehabilitation therapy, surgical treatment, and the like, but long-term administration is not suitable because of the large side effects of chemical drugs, particularly hormones. The traditional Chinese medicine decoction for treating chronic obstructive disease in the market is inconvenient to take and bitter in taste, and compliance of patients is reduced.
Disclosure of Invention
In view of the above, the present invention aims to provide moxibustion powder for treating chronic obstructive pulmonary diseases, and a preparation method and applications thereof, so that the moxibustion powder has a significant curative effect on chronic obstructive pulmonary diseases.
In order to achieve the above purpose, the invention provides the following technical scheme:
a moxibustion powder for the treatment of chronic obstructive pulmonary disease comprises Ginseng radix Rubri, herba et Gemma Agrimoniae, Bulbus Fritillariae Cirrhosae, fructus Perillae, parched semen Lepidii, semen Sinapis Albae, fructus Psoraleae, lignum Santali albi, exocarpium Citri rubrum, radix Paeoniae Rubra, flos Caryophylli, cortex Cinnamomi, Moschus, folium Artemisiae Argyi and Uighur medicine semen Nigellae volatile oil.
The moxibustion powder is an external traditional Chinese medicine for treating chronic obstructive pulmonary diseases. Chronic obstructive pulmonary disease belongs to the categories of cough, asthma, lung distension and the like in traditional Chinese medicine. The lung is affected by pathogenic factors, delayed treatment is caused, phlegm and blood stasis are lingered, healthy qi is damaged, the lung, the spleen and the kidney are damaged, the healthy qi is weakened, the defensive qi is not fixed, exogenous factors are easy to invade repeatedly, the attack of the disease is induced, and the pathological change is that the principal is deficient and the secondary is excessive. In the acute exacerbation stage, excess is the main cause, and is caused by phlegm (phlegm-heat, turbid phlegm) obstruction or phlegm-stasis obstruction, often accompanied by qi deficiency or qi-yin deficiency; deficiency is predominant in the stationary phase, qi (yang) is predominant in yin deficiency, lung and spleen and kidney deficiency are predominant in lung and kidney, and phlegm-stasis is often accompanied. According to the invention, according to the principle of assistant and guide, red ginseng, hairyvein agrimony, bulbus fritillariae cirrhosae, perilla seed, fried semen lepidii, semen brassicae, fructus psoraleae, sandalwood, exocarpium citri rubrum, radix paeoniae rubra, flos caryophyllata, cinnamon, musk and artemisia argyi are selected from a plurality of traditional Chinese medicines to form a compound, and each traditional Chinese medicine is applied to the pain point of the acupuncture point related to the cough due to the deficiency of lung-spleen qi, so that the compound has synergistic effect and treats the cough due to the deficiency of lung-.
Wherein, red ginseng is sweet and slightly bitter in taste and warm in nature. It enters spleen, lung and heart meridians. Has the effects of invigorating primordial qi, restoring pulse, relieving depletion, invigorating qi, and regulating blood. Can be used for treating asthenia, collapse, cold limbs, slight pulse, qi deficiency, blood disorder, metrorrhagia, and metrostaxis; heart failure, cardiogenic shock.
Herba et Gemma Agrimoniae, also called JIELILI grass or SHI TU, is a common hemostatic with heart tonifying effect. Has effects of astringing, stopping bleeding, removing toxic substance, treating sore, killing parasite, astringing sweat, and relieving cough. Can be used for treating hemoptysis, hematemesis, epistaxis, hematuria, metrorrhagia, dysentery with bloody stool, malaria, diabetes, hyperhidrosis, traumatic cough, etc., and can be used for treating trichomonas vaginitis, furuncle, sore, carbuncle, and hemorrhoid.
The parched semen Lepidii has the effects of purging lung-fire, lowering qi, eliminating phlegm, relieving asthma, inducing diuresis, relieving swelling, clearing heat and eliminating evil. It can be used for treating cough, asthma, excessive phlegm, pulmonary abscess, edema, hydrothorax and abdominal dropsy, dysuresia, chronic pulmonary heart disease, and asthma and swelling due to heart failure. It is also indicated for abscess, deep-rooted carbuncle, malignant boil, scrofula and tuberculosis.
Semen Sinapis Albae enters into the Taiyin channel of hand, and has effects of warming lung, eliminating phlegm, benefiting qi, resolving hard mass, dredging collaterals, relieving pain, eliminating phlegm, resolving hard mass, and relieving swelling. Can be used for treating cough, asthma, excessive phlegm, chest distress, hypochondriac pain, numbness of limbs, joint swelling and pain, damp phlegm, abscess, mammary abscess, breast cancer, mammary gland pain, tuberculosis, phlegm retention, cough, distention and pain of chest and hypochondrium, regurgitation, emesis, apoplexy, numbness of limbs, tinea pedis, dorsal furuncle, toxic swelling, and traumatic injury.
Bu Gu Zhi is bitter and pungent in flavor and warm in nature. It enters kidney and spleen meridians. Has the effects of tonifying kidney and strengthening yang, securing essence and reducing urination, warming spleen and checking diarrhea, and absorbing qi and relieving asthma. It can be used for treating sexual impotence due to kidney deficiency, soreness of waist and knees, psychroalgia, spermatorrhea, enuresis, frequent micturition, etc.
Sandalwood is pungent in flavor, warm in nature and non-toxic. Enter spleen, stomach and lung meridians. Has the effects of regulating qi and harmonizing stomach. It can be used for treating pain in heart and abdomen, dysphagia, emesis, and chest distress.
Tangerine peel is pungent, bitter and warm in nature. It enters lung and spleen meridians. Has the effects of dispelling cold, eliminating dampness, activating qi-flowing, and eliminating phlegm. Can be used for treating cough due to wind-cold evil, itching throat, excessive phlegm, food stagnation, alcohol injury, nausea, vomiting, and stuffiness.
Red peony root: bitter in taste and slightly cold in nature. It enters liver meridian. Has effects of removing blood stasis, relieving pain, cooling blood, and relieving swelling. It can be used for treating amenorrhea due to blood stasis, hernia, abdominal mass, abdominal pain, hypochondriac pain, epistaxis, dysentery with blood, intestinal wind, conjunctival congestion, carbuncle, and swelling.
Chuan Bei mu is bitter and sweet in taste and slightly cold in nature. It enters lung and heart meridians. Has effects in clearing away heat, eliminating phlegm, and relieving cough, and can be used for treating cough and asthma due to phlegm-heat, and yellow and thick expectoration; it is also sweet in flavor, so it excels in moistening lung to arrest cough, and can be used to treat cough with dry heat in lung manifested as scanty and sticky phlegm, and cough with deficiency syndrome such as yin deficiency and dry cough; it also has the action of resolving masses and resolving stagnation, and can be used for treating chest distress, vexation, scrofula, subcutaneous nodule, etc. due to accumulation of phlegm and heat.
Flos Caryophylli is pungent in flavor and warm in nature. Enters the lung, spleen, stomach and kidney meridians. Has effects of warming spleen and stomach, warming kidney, and lowering adverse qi. It can be used for treating singultus, emesis, regurgitation, dysentery, psychroalgia, bubo, hernia, and tinea.
Rou Gui is strongly hot in nature, pungent and sweet in flavor. It can be used for treating decline of vital gate fire, cold limbs, weak pulse, yang exhaustion, abdominal pain, diarrhea, cold hernia, cold pain of waist and knee, amenorrhea, cellulitis in yin, multiple abscess, and floating yang, upper heat and lower cold.
Musk is pungent in flavor and warm in nature. Entering heart, spleen and liver meridians, it has the functions of inducing resuscitation, removing filth, dredging collaterals and dispelling blood stasis. Can be used for treating apoplexy, phlegm syncope, infantile convulsion, aversion to cold, vexation, heart and abdominal pain, traumatic injury, carbuncle, cellulitis, and toxic swelling.
Perilla seed, fructus Perillae, is pungent in flavor and warm in nature. It enters lung meridian. Has effects in lowering qi, eliminating phlegm, relieving asthma, and moistening intestine. Raw perilla has strong effect of lubricating intestines, and is often used for constipation due to intestinal dryness or asthma accompanied by constipation.
The aged wormwood fine powder has multiple functions: 1. local stimulation: it has effects in promoting topical skin hyperemia and telangiectasia, improving topical blood circulation and lymph circulation, relieving and eliminating smooth muscle spasm, improving topical skin tissue metabolism, and promoting the dissipation and absorption of pathological products such as inflammatory adhesion exudate and hematoma. 2, regulating the channels and collaterals; 3, immune regulation; 4, warming channel for dispelling cold; 5, promoting the circulation of qi and removing obstruction in channels; 6 strengthening yang and relieving depletion; 7, drawing out poison and clearing heat; 8 preventing diseases and promoting health.
Preferably, the traditional Chinese medicine composition comprises, by weight, 5-15 parts of red ginseng, 10-20 parts of hairyvein agrimony, 1-10 parts of bulbus fritillariae cirrhosae, 10-20 parts of perilla fruit, 10-20 parts of fried pepperweed seed, 10-20 parts of semen brassicae, 10-20 parts of fructus psoraleae, 5-15 parts of sandalwood, 5-15 parts of exocarpium citri rubrum, 10-20 parts of radix paeoniae rubra, 1-10 parts of flos caryophylli, 10-20 parts of cinnamon, 1-5 parts of musk, 5-15 parts of artemisia argyi and 3-20 parts of Victoria nigella volatile oil.
Further preferably, the medicine comprises, by weight, 10 parts of red ginseng, 15 parts of hairyvein agrimony, 7 parts of bulbus fritillariae cirrhosae, 15 parts of perilla fruit, 15 parts of fried pepperweed seed, 15 parts of white mustard seed, 15 parts of fructus psoraleae, 10 parts of sandalwood, 9 parts of exocarpium citri rubrum, 15 parts of red paeony root, 8 parts of flos caryophyllata, 15 parts of cinnamon, 1 part of musk, 10 parts of old wormwood and 10 parts of Uighur medicine nigella sativa seed volatile oil; in a specific embodiment of the invention, 1g represents one portion, and the moxibustion powder comprises 10g of red ginseng, 15g of hairyvein agrimony, 7g of bulbus fritillariae cirrhosae, 15g of perilla fruit, 15g of fried lepidium seed, 15g of semen brassicae, 15g of fructus psoraleae, 10g of sandalwood, 9g of exocarpium citri rubrum, 15g of radix paeoniae rubra, 8g of flos caryophylli, 15g of cortex cinnamomi, 1g of musk, 10g of old folium artemisiae and 10g of Uygur medicine nigella sativa seed volatile oil.
Preferably, the aged moxa is selected from aged moxa for more than 5 years and is ground into fine powder.
On the basis of the compound prescription, the contrast compound prescription is formed by carrying out deficiency and is compared with the moxibustion powder disclosed by the invention on the curative effect of the chronic obstructive pulmonary disease, and the result shows that the significant efficiency of the contrast compound prescription is only 10-35%, while the significant efficiency of the moxibustion powder disclosed by the invention is as high as 91%, and the cure rate is as high as 65%, and the effect is extremely obvious compared with that of each contrast compound prescription. In view of the excellent effect, the invention provides the application of the moxibustion powder in preparing the external traditional Chinese medicine for treating chronic obstructive pulmonary disease.
Meanwhile, the invention also provides a preparation method of the moxibustion powder, which comprises the steps of weighing red ginseng, hairyvein agrimony, bulbus fritilariae, perilla fruit, fried lepidium seed, semen brassicae, fructus psoraleae, sandalwood, exocarpium citri rubrum, radix paeoniae rubra, flos caryophyllata, cortex cinnamomi and musk, baking, crushing into powder, mixing with the aged moxa fine powder, adding the volatile oil of the Uighur medicine nigella sativa fruit and stirring uniformly to obtain the moxibustion powder.
Wherein, preferably, the baking is performed by microwave baking; the crushed mesh number is 100 meshes.
In a specific embodiment of the present invention, the preparation method is as follows:
weighing 10 parts of red ginseng, 15 parts of hairyvein agrimony, 7 parts of bulbus fritillariae cirrhosae, 15 parts of perilla fruit, 15 parts of fried semen lepidii, 15 parts of semen brassicae, 15 parts of fructus psoraleae, 10 parts of sandalwood, 9 parts of exocarpium citri rubrum, 15 parts of radix paeoniae rubra, 8 parts of flos caryophylli, 15 parts of cinnamon and 1 part of musk according to the proportion, placing the mixture in a microwave oven for 2 minutes, baking the mixture, crushing the mixture, sieving the mixture by a 100-mesh sieve, and placing the mixture;
grinding old folium Artemisiae Argyi for more than 5 years into fine powder, sieving with 100 mesh sieve, and sealing in a glass container;
mixing the prepared traditional Chinese medicine powder and 10 parts of old moxa fine powder, adding the Uygur medicine nigella sativa seed volatile oil, and fully stirring to obtain the moxibustion powder.
According to the technical scheme, the red ginseng and the hairyvein agrimony are used as monarch drugs; bulbus Fritillariae Cirrhosae, fructus Perillae, semen Lepidii preparata, and semen Sinapis Albae as ministerial drugs, and adjuvant monarch drugs for enhancing dredging, removing blood stasis, and smoothing lung qi to achieve antitussive and expectorant effects; fructus Psoraleae, lignum Santali albi, exocarpium Citri rubrum, radix Paeoniae Rubra, flos Caryophylli, cortex Cinnamomi, and Moschus as adjuvant drugs; the old moxa fine powder is used for tonifying qi and strengthening the middle warmer, and is used for harmonizing the medicines to play the effects of clearing lung and relieving cough, and reducing phlegm and relieving asthma, thereby treating the chronic obstructive pulmonary disease.
Detailed Description
The invention discloses moxibustion powder for treating chronic obstructive pulmonary disease and a preparation method and application thereof, and can be realized by appropriately improving process parameters by referring to the contents in the field. It is expressly intended that all such similar substitutes and modifications which would be obvious to one skilled in the art are deemed to be included in the invention. While the moxibustion powder and the preparation method thereof have been described in terms of preferred embodiments, it will be apparent to those skilled in the art that the technology of the present invention can be implemented and applied by modifying or appropriately changing or combining the moxibustion powder and the preparation method thereof without departing from the content, spirit and scope of the invention.
When the moxibustion powder is used, the mixed moxibustion powder is directly applied to the points of the large vertebra related to obstructive pulmonary diseases and the governor vessel of the lumbosacral part, and the two sides of the back governor vessel of a patient are conventionally disinfected by 75% alcohol from top to bottom for 3 times; coating ginger juice along two sides of the governor vessel on the back; scattering moxibustion powder into strips along two sides of a governor vessel on the back; covering mulberry paper on the medicinal powder; placing olive-shaped moxa cone on the ginger paste in a imbricate shape; selecting the upper, middle and lower three points of the moxa cone to be ignited; 3-inch moxibustion is finished continuously; taking down the ginger paste after 3 rd strong moxibustion; wiping the medicinal mud with warm and wet towel. The life of sports, work, study, bathing, etc. is not affected after treatment. The traditional Chinese medicine composition is more convenient, efficient, time-saving, labor-saving and easy to operate in treating cough caused by deficiency of lung qi and spleen qi.
The moxibustion powder for treating chronic obstructive pulmonary disease provided by the invention, the preparation method and the application thereof are further explained below.
Example 1: the invention relates to moxibustion powder
Weighing 10g of red ginseng, 15g of hairyvein agrimony, 7g of bulbus fritillariae cirrhosae, 15g of perilla fruit, 15g of fried lepidium seed, 15g of white mustard seed, 15g of fructus psoraleae, 10g of sandalwood, 9g of exocarpium citri rubrum, 15g of red paeony root, 8g of flos caryophyllata, 15g of cinnamon and 1g of musk according to the proportion, placing the mixture in a microwave oven for 2 minutes, baking the mixture, crushing the mixture, sieving the mixture by a 100-mesh sieve, and placing the mixture in;
grinding old folium Artemisiae Argyi for more than 5 years into fine powder, sieving with 100 mesh sieve, and sealing in a glass container;
mixing the above obtained Chinese medicinal powder and 10g of old folium Artemisiae Argyi fine powder, adding 10g of Uighur medicine semen Nigellae volatile oil, and stirring thoroughly to obtain the moxibustion powder.
Example 2: comparison of therapeutic effects with different combinations
Case selection: 80 patients are selected from each group, and the diagnosis meets the standard specified in the guidance for diagnosis and treatment of chronic obstructive pulmonary disease (revised 2013) issued by the respiratory disease classification of Chinese medical society in 2013. The selected cases are in acute stage, do not contain other extrapulmonary diseases, and do not use theophylline medicines and systemically use corticosteroid medicines within 1 week. 50-55 men and 25-30 women among 80 patients are 46.1-88.2 years old, and the average age is 65.4 +/-22.1 years old. Selected cases were excluded: the hormone-dependent patients have severe heart, liver, renal insufficiency, acute myocardial infarction, pregnant women and lactating women.
The treatment method comprises the following steps: when each group is used, the mixed moxibustion powder is directly applied to the points of the large vertebra related to obstructive pulmonary diseases and the governor vessel at the lumbosacral part, and the two sides of the back governor vessel of a patient are disinfected by 75 percent alcohol from top to bottom for 3 times in a conventional way; coating ginger juice along two sides of the governor vessel on the back; scattering moxibustion powder into strips along two sides of a governor vessel on the back; covering mulberry paper on the medicinal powder; placing olive-shaped moxa cone on the ginger paste in a imbricate shape; selecting the upper, middle and lower three points of the moxa cone to be ignited; 3-inch moxibustion is finished continuously; taking down the ginger paste after 3 rd strong moxibustion; wiping the medicinal mud with warm and wet towel.
And (3) judging the curative effect: the effect is shown: the symptoms of breathing and wheezing are obviously relieved or disappeared, and the daily life is not influenced; the wheeze in the lung disappears completely or is obviously reduced; FEV1, FEV1/FVC, PEF and PO2Increase > 25%, PCO2The reduction is > 25%.
Improvement: the symptoms of cough and wheeze are reduced but not completely disappeared and can be tolerated; lung wheezes are reduced but not completely eliminated; FEV1, FEV1/FVC, PEF and PO2Increase by 15-24%, PCO2The reduction is 15 to 24 percent.
And (4) invalidation: no relief or exacerbation of cough, wheezing; lung wheezes are not reduced or increased; FEV1, FEV1/FVC, PEF and PO2Increase < 15%, PCO2The reduction is less than 15%.
Control recipe 1: 15g of hairyvein agrimony, 7g of bulbus fritillariae cirrhosae, 15g of perilla fruit, 15g of fried pepperweed seed, 15g of white mustard seed, 15g of fructus psoraleae, 10g of sandalwood, 9g of tangerine, 15g of red paeony root, 8g of flos caryophyllata, 15g of cinnamon, 1g of musk and 10.0g of old moxa fine powder (compared with the embodiment 1, 10g of red ginseng is not used);
control recipe 2: red ginseng 10g, bulbus fritillariae cirrhosae 7g, perilla seed 15g, parched semen lepidii 15g, white mustard seed 15g, psoralea fruit 15g, sandalwood 10g, exocarpium citri rubrum 9g, red peony root 15g, flos caryophylli 8g, cinnamon 15g, musk 1g and old mugwort fine powder 10.0g (comparing with example 1 and lacking herba agrimoniae 15 g);
control recipe 3: 10g of red ginseng, 15g of hairyvein agrimony, 15g of perilla seed, 15g of fried lepidium seed, 15g of white mustard seed, 15g of malaytea scurfpea fruit, 10g of sandalwood, 9g of tangerine, 15g of red paeony root, 8g of flos caryophyllata, 15g of cinnamon, 1g of musk and 10.0g of old moxa fine powder (compared with the embodiment 1, 7g of unibract fritillary bulb is absent);
control recipe 4: red ginseng 10g, hairyvein agrimony 15g, bulbus fritillariae cirrhosae 7g, parched semen lepidii 15g, semen brassicae 15g, fructus psoraleae 15g, sandalwood 10g, exocarpium citri rubrum 9g, radix paeoniae rubra 15g, flos caryophylli 8g, cortex cinnamomi 15g, musk 1g and old folium artemisiae fine powder 10.0g (compared with example 1, the perilla seed is not used 15 g);
control recipe 5: 10g of red ginseng, 15g of hairyvein agrimony, 7g of bulbus fritillariae cirrhosae, 15g of perilla fruit, 15g of fried lepidium seed, 15g of white mustard seed, 15g of fructus psoraleae, 10g of sandalwood, 9g of exocarpium citri rubrum, 15g of red paeony root, 8g of flos caryophylli, 15g of cinnamon and 10.0g of old moxa fine powder (compared with the embodiment 1, 1g of musk is not used);
control recipe 6: red ginseng 10g, hairyvein agrimony 15g, bulbus fritillariae cirrhosae 7g, perilla seed 15g, parched semen lepidii 15g, white mustard seed 15g, fructus psoraleae 15g, sandalwood 10g, exocarpium citri rubrum 9g, red peony root 15g, flos caryophylli 8g, cinnamon 15g and musk 1g (compared with embodiment 1, the old moxa fine powder is 10 g);
TABLE 1
Group of | No recurrence for more than 1 year | Show effect | Improvement of life | Invalidation |
Example 1 | 65% | 91% | 96% | 4% |
Control Compound 1 | 15% | 33% | 60% | 40% |
Control Compound 2 | 10% | 15% | 61% | 39% |
Control Compound 3 | 14% | 18% | 56% | 44% |
Control Compound 4 | 15% | 21% | 59% | 41% |
Control Compound 5 | 8% | 20% | 45% | 55% |
Control Compound 6 | 13% | 23% | 54% | 46% |
The data in the table above are rounded using a rounding method for convenience of statistics.
As is evident from Table 1, the significant efficiency of the control compound is only 10-35%, while the significant efficiency of the moxibustion powder of the invention is as high as 91%, the cure rate is as high as 65%, and the effect is very significant compared with the control compound.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (6)
1. The moxibustion powder for treating the chronic obstructive pulmonary disease is characterized by comprising, by weight, 10 parts of red ginseng, 15 parts of hairyvein agrimony, 7 parts of bulbus fritillariae cirrhosae, 15 parts of perilla fruit, 15 parts of fried pepperweed seed, 15 parts of semen brassicae, 15 parts of fructus psoraleae, 10 parts of sandalwood, 9 parts of exocarpium citri rubrum, 15 parts of red paeony root, 8 parts of flos caryophyllata, 15 parts of cinnamon, 1 part of musk, 10 parts of artemisia argyi and 10 parts of Uighur medicine nigella sativa seed volatile oil.
2. The moxibustion powder of claim 1, wherein the aged moxa is aged moxa for more than 5 years.
3. Use of the moxibustion powder of any one of claims 1-2 in the preparation of an external traditional Chinese medicine for treating chronic obstructive pulmonary disease.
4. The method for preparing moxibustion powder of claim 1, wherein red ginseng, hairyvein agrimony, bulbus fritilariae, perilla fruit, fried lepidium seed, semen brassicae, fructus psoraleae, sandalwood, exocarpium citri rubrum, radix paeoniae rubra, flos caryophyllata, cinnamon and musk are weighed, baked and crushed into powder, then mixed with the refined powder of artemisia argyi, the volatile oil of the nigella sativa seeds of the Uighur drug tumor is added, and the mixture is stirred uniformly to obtain the moxibustion powder.
5. The method according to claim 4, wherein the torrefaction is performed by microwave torrefaction.
6. The method according to claim 4, wherein the crushed material has a mesh size of 100 meshes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810156580.1A CN108057089B (en) | 2018-02-24 | 2018-02-24 | Moxibustion powder for treating chronic obstructive pulmonary disease and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810156580.1A CN108057089B (en) | 2018-02-24 | 2018-02-24 | Moxibustion powder for treating chronic obstructive pulmonary disease and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108057089A CN108057089A (en) | 2018-05-22 |
CN108057089B true CN108057089B (en) | 2021-03-02 |
Family
ID=62134397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810156580.1A Active CN108057089B (en) | 2018-02-24 | 2018-02-24 | Moxibustion powder for treating chronic obstructive pulmonary disease and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108057089B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115025174B (en) * | 2022-06-28 | 2023-06-02 | 杨永华 | A Chinese medicinal composition for treating chronic obstructive pulmonary disease, and its preparation method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251690A (en) * | 2013-02-26 | 2013-08-21 | 中国人民解放军新疆军区联勤部药品仪器检验所 | Application of Uighur drug nigella glandulifera preyn seed volatile oil in chronic obstructive pulmonary disease drug preparation |
CN105287726A (en) * | 2015-12-10 | 2016-02-03 | 辽宁中医药大学附属医院 | Traditional Chinese medicine preparation applied to Yongquan acupoint for preventing and treating repeated attack of cough and asthma of chronic pulmonary system diseases |
CN106333984A (en) * | 2016-09-26 | 2017-01-18 | 田忠新 | Moxibustion powder and preparation method thereof |
-
2018
- 2018-02-24 CN CN201810156580.1A patent/CN108057089B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251690A (en) * | 2013-02-26 | 2013-08-21 | 中国人民解放军新疆军区联勤部药品仪器检验所 | Application of Uighur drug nigella glandulifera preyn seed volatile oil in chronic obstructive pulmonary disease drug preparation |
CN105287726A (en) * | 2015-12-10 | 2016-02-03 | 辽宁中医药大学附属医院 | Traditional Chinese medicine preparation applied to Yongquan acupoint for preventing and treating repeated attack of cough and asthma of chronic pulmonary system diseases |
CN106333984A (en) * | 2016-09-26 | 2017-01-18 | 田忠新 | Moxibustion powder and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
益肺灸治疗慢性阻塞性肺疾病稳定期的研究进展;孙辉等;《中国中医药现代远程教育》;20160131;第14卷(第1期);第146-147页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108057089A (en) | 2018-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104524335B (en) | A kind of pill and preparation method for female endocrine dyscrasia conditioning | |
CN115837065A (en) | Traditional Chinese medicine composition and application thereof | |
CN103432412B (en) | Medicament for treating hyperplasia of mammary glands and preparation method thereof | |
CN102397335A (en) | Pure traditional Chinese medicine composition for treating poultry fatty liver hemorrhagic syndrome and preparation method thereof | |
CN108057089B (en) | Moxibustion powder for treating chronic obstructive pulmonary disease and preparation method and application thereof | |
CN108245611B (en) | Moxibustion powder for treating cough caused by deficiency of lung qi and spleen qi as well as preparation method and application of moxibustion powder | |
CN105770691A (en) | Medicinal preparation for treating cervical cancer and application thereof | |
CN105998495A (en) | Traditional Chinese medicine composition for treating scald and preparation method thereof | |
CN104524277A (en) | Traditional Chinese medicine mixture for treating anorexia nervosa | |
CN105521246A (en) | Medicinal preparation for treating lung cancer and applications of medicinal preparation | |
CN103908616A (en) | Medicament for relieving radiation side reactions of cancer patients and preparation method thereof | |
CN114452369B (en) | Traditional Chinese medicine composition for treating breast cancer | |
CN111956759B (en) | Tibetan medicine composition for adjuvant treatment of lung cancer and preparation method thereof | |
CN109364181A (en) | A kind of Chinese medicine composition for treating gout, Chinese medicine and preparation method thereof | |
CN115154568B (en) | Traditional Chinese medicine composition for treating thyroid nodule and preparation method and application thereof | |
CN103638499B (en) | Medicament for treating osteoarticular tuberculosis and preparation method of medicament | |
CN100371016C (en) | Chinese traditional medicine preparation for curing mastopathy in installments | |
CN105597004A (en) | Traditional Chinese medicine combination for treating cancer | |
CN100363051C (en) | Mastoproliferation treating Chinese medicine and its prepn | |
CN106074960A (en) | A kind of Chinese medicine composition treating breast carcinoma and cyclomastopathy and preparation method thereof | |
CN104906491A (en) | Pure traditional Chinese medicine composition for treating infectious bursal disease of poultry and preparing methd thereof | |
CN111658739A (en) | Composition for eliminating breast nodules and preparation method and application thereof | |
CN118845968A (en) | Composite preparation for treating cancer and preparation method thereof | |
CN113694110A (en) | Incadronate disodium product and preparation method thereof | |
CN117281876A (en) | Traditional Chinese medicine external treatment medicine bag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |